Catalog #SIM0078

InVivoSIM anti-human IL-31RA (Nemolizumab Biosimilar)

Clone Nemolizumab
Reactivities Human
Isotype Human IgG2, κ

$243.00 - $8,425.00

$243.00 - $8.00

Choose an Option...
  • 100 mg - $8,425.00
  • 50 mg - $4,734.00
  • 25 mg - $3,293.50
  • 5 mg - $943.00
  • 1 mg - $243.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left
  • US Customers - Order by Noon EDT on Monday to receive by June 9.
  • Product Description

    This non‑therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody Nemolizumab making it ideal for research use. Nemolizumab is a humanized IgG2 monoclonal antibody that specifically targets the interleukin-31 receptor alpha (IL-31RA). IL‑31RA is primarily expressed on keratinocytes, dorsal root ganglion (DRG) neurons, monocytes, macrophages, and dendritic cells, where it mediates the biological effects of IL‑31, a cytokine known for driving pruritus, inflammation, and epithelial barrier dysfunction. By binding to IL-31RA, it blocks the signaling of interleukin-31 (IL‑31)—a neuroimmune cytokine that drives itch (pruritus), skin inflammation, barrier dysfunction, and fibrosis—thereby interrupting the pathogenic itch–scratch cycle seen in skin disorders like atopic dermatitis (AD) and prurigo nodularis (PN) . Nemolizumab has been shown to provide rapid and sustained relief of pruritus in clinical trials involving AD and PN by modulating neuroimmune pathways, improving skin integrity, and reducing inflammation . This Nemolizumab biosimilar is well suited for studying IL‑31 signaling, neuroimmune interactions in itch, barrier function, and the development of anti-pruritic therapeutics.

    Specifications

    Isotype Human IgG2, κ
    Recommended Isotype Control(s) RecombiMAb human IgG2 isotype control, anti-hen egg lysozyme
    Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
    Mutations C130S/R132K/E136G/S137G/C218S/ H263Q/R350Q/Q414E/G441DEL/K442DEL
    Immunogen Human IL-31RA
    Reported Applications in vivo functional assays
    in vitro functional assays
    Flow cytometry
    ELISA
    Formulation PBS, pH 7.0
    Contains no stabilizers or preservatives
    Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
    Determined by LAL assay
    Aggregation <5%
    Determined by SEC
    Purity ≥95%
    Determined by SDS-PAGE
    Sterility 0.2 µm filtration
    Production Purified from cell culture supernatant in an animal-free facility
    Purification Protein A
    Molecular Weight 150 kDa
    Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
    Need a Custom Formulation? See All Antibody Customization Options

    Product FAQs